An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

Summary

The purpose of this study is to assess the efficacy and pattern of use of the combination drug product SM-1 in adults who sometimes have difficulty in falling asleep or staying asleep, but who do not have chronic insomnia. Participants will receive SM-1 or placebo to take at home as needed over the course of 3 months treatment period.

Timeline

Start

2023-05

Primary completion

2023-12

Completion

2023-12

Outcome

Outcome not reported

Stopped (Enrollment): “no participants enrolled”

Drugs

Indications